Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascites

Critical Care Medicine

Volumn 33, Issue 9, 2005, Pages 2028-2033

  Ferlitsch, Arnulf ^a   Pleiner, Johannes ^a   Mittermayer, Friedrich ^a   Schaller, Georg ^a   Homoncik, Monika ^a   Peck Radosavljevic, Markus ^a   Wolzt, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidants; Cirrhosis; Forearm blood flow; Liver; Vasoconstriction

Indexed keywords

ANGIOTENSIN ANTAGONIST; ASCORBIC ACID; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIOXIDANT ACTIVITY; ARTICLE; ASCITES; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; FEMALE; FOREARM BLOOD FLOW; HUMAN; LIVER FUNCTION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; VASOCONSTRICTION;

EID: 24944489381     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000178173.27923.EB     Document Type: Article

References (45)

1. Murray JF, Dawson AM, Sherlock S: Circulatory changes in cirrhotic liver disease. Am J Med 1958; 32:358-367
2. Kontos HA, Shapiro W, Mauck HP, et al: General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964; 37:526-535
3. Kowalski HJ, Abelman WH: Cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953; 32:1025-1033
4. MacGilchrist AJ, Sumner D, Reid JL: Impaired pressor reactivity in cirrhosis: Evidence for a peripheral vascular defect. Hepatology 1991; 13:689-694
5. Helmy A, Jalan R, Newby DE, et al: Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology 2000; 118:565-572
6. Wiest R, Groszmann RJ: The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 2002; 35:478-491
7. Gonzalez-Abraldes J, Garcia-Pagan JC, Bosch J: Nitric oxide and portal hypertension. Metab Brain Dis 2002; 17:311-324
8. Rosser BG, Gores GJ: Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 1995; 108:252-275
9. Bomzon A, Ljubuncic P: Oxidative stress and vascular smooth muscle cell function in liver disease. Pharmacol Ther 2001; 89:295-308
10. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M: Oxidative stress in the blood of patients with alcohol-related liver cirrhosis. Med Sci Monit 2002; 8:CR419-CR424
11. Laffi G, Foschi M, Masini E, et al: Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 1995; 22:1666-1673
12. Chin-Dusting JP, Rasaratnam B, Jennings GL, et al: Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med 1997; 127:985-988
13. Pleiner J, Heere-Ress E, Langenberger H, et al: Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 2002; 22:95-100
14. Pleiner J, Mittermayer F, Schaller G, et al: Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 2003; 42:1656-1662
15. Frei B, England L, Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989; 86:6377-6381
16. Pleiner J, Mittermayer F, Schaller G, et al: High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm. Circulation 2002; 106:1460-1464
17. Hokanson DE, Sumner DS, Strandness DE: An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975; 22:25-29
18. Benjamin N, Calver A, Collier J, et al: Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995; 25:918-923
19. Ting HH, Timimi FK, Boles KS, et al: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97:22-28
20. O. Bayerle-Eder M, Pleiner J, Mittermayer F, et al: Effect of systemic vitamin C on free fatty acid-induced lipid peroxidation. Diabetes Metab 2004; 30:433-439
21. Chen MF, Mo LR, Lin RC, et al: Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med 1997; 23:672-679
22. Aboutwerat A, Pemberton PW, Smith A, et al: Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim Biophys Acta 2003; 1637:142-150
23. !3. Jain SK, Pemberton PW, Smith A, et al: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36:805-811
24. Van de Casteele M, Zaman Z, Zeegers M, et al: Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself. Aliment Pharmacol Ther 2002; 16:985-992
25. Fernando B, Marley R, Holt S, et al: N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 1998; 28:689-694
26. Langlois M, Duprez D, Delanghe J, et al: Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001; 103:1863-1868
27. Jackson TS, Xu A, Vita JA: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998; 83:916-922
28. Kirsch M, de Groot H: Ascorbate is a potent antioxidant against peroxynitrite-induced oxidation reactions. Evidence that ascorbate acts by re-reducing substrate radicals produced by peroxynitrite. J Biol Chem 2000; 275:16702-16708
29. Guarner C, Soriano G, Tomas A, et al: Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18:1139-1143
30. Arroyo V, Jimenez W: Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32:157-170
31. Bindoli A, Rigobello MP, Deeble DJ: Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992; 13:391-405
32. Macarthur H, Westfall TC, Riley DP, et al: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 2000; 97:9753-9758
33. Ryan J, Jennings G, Dudley F, et al: Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis. Clin Sci 1996; 91:23-28
34. Ryan J, Sudhir K, Jennings G, et al: Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993; 105:1167-1172
35. Newby DE, Jalan R, Masumori S, et al: Peripheral vascular tone in patients with cirrhosis: Role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res 1998; 38:221-228
36. Vaughan RB, Angus PW, Chin-Dusting JP: Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation. Gut 2003; 52:1505-1510
37. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 8670:997-1000
38. Helmy A, Newby DE, Jalan R, et al: Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide. Gut 2003; 52:410-415
39. Martin PY, Xu DL, Niederberger M, et al: Upregulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats. Am J Physiol 1996; 270:F494-F499
40. Cahill PA, Redmond EM, Hodges R, et al: Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol 1996; 25:370-378
41. Ottesen LH, Harry D, Frost M, et al: Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001; 31:790-798
42. Sanz-Cameno P, Medina J, Garcia-Buey L, et al: Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002; 37:723-729
43. Cuzzocrea S, Zingarelli B, Villari D, et al: Evidence for in vivo peroxynitrite production in human chronic hepatitis. Life Sci 1998; 63:PL25-PL30
44. Ducrocq C, Dendane M, Laprevote O, et al: Chemical modifications of the vasoconstrictor peptide angiotensin II by nitrogen oxides (NO, HNO2, HOONO)-evaluation by mass spectrometry. Eur J Biochem 1998; 253:146-153
45. Cudic M, Dendane M, Houe-Levin C, et al: Nitration of angiotensin II by NO2 radicals and peroxynitrite. NO protects against NO2 radical reaction. Eur J Biochem 1999; 265:967-971